ESTROGEN CREAM
Report #6929
Topical estrogen cream is effective for preventing thinning of the skin, wrinkling and spotting on the faces of postmenopausal women (1,2,3,4).
All women suffer a progressive thinning of bones and skin after the menopause. As a result, they develop weak bones and thin skin. Estrogen pills reduce bone loss significantly, but they do not halt the 8.6% reduction in skin thickness that occurs every 10 years after the menopause. On the other hand, doctors have known for more than 50 years that lack of estrogen at the time of the menopause often causes a woman's vagina to become dry and thin and that vaginal creams containing estrogen help prevent this. Doctors asked postmenopausal women to apply readily available/ commercial/ vaginal estrogen creams to their faces three times a week. After 6 months, their faces had less wrinkling, fewer dark spots and a more youthful appearance. Doctors know that estrogen pills can cause uterine cancer unless postmenopausal women are also given progesterone. Therefore, they usually give progesterone with estrogen pills to women who have not had a hysterectomy. However, studies show that after 6 months of applying estrogen creams to the face three times a week, there were no precancerous changes in the uterus, no rise in blood levels of estrogen and no change in the brain hormones that control estrogen production. Since vaginal creams are thick and greasy, your doctor can write a prescription for your pharmacist to make a more elegant cream by adding 18.75 mg of Premarin powder to one ounce of facial cream. or writing a prescription for 0.01% estradiol in any facial cream.
By Gabe Mirkin, M.D., for CBS Radio News
1) JB Schmidt, M Binder, G Demschik, C Bieglmayer, A Reiner. Treatment of skin aging with topical estrogens. International Journal of Dermatology 35: 9 (SEP 1996): 669-674. The effects of 0.01% estradiol and 0.3% estriol compounds. Conclusions. Both estrogen compounds were found to be highly effective in preventing or treating skin aging in perimenopausal women, clinically, by measurement data, and by an increase in collagen Type III.
2) DC Bauer, D Grady, A Pressman, SR Cummings, D Black, HK Genant, C Arnaud, W Browner, L Christianson, M Dockrell, C Fox, C Gluer, S Harvey, M Jergas et al. Skin thickness, estrogen use, and bone mass in older women. Menopause - the Journal of the North American Menopause Society 1: 3 (FAL 1994): 131-136.
3) JB Schmidt, M Binder, W Macheiner, C Kainz, G Gitsch, C Bieglmayer. Treatment of skin ageing symptoms in perimenopausal females with estrogen compounds. A pilot study. Maturitas 20: 1 (NOV 1994): 25-30.
4) P Creidi, B Faivre, P Agache, E Richard, V Haudiquet, JP Sauvanet. Effect of a conjugated oestrogen (Premarin(R)) cream on ageing facial skin. A comparative study with a placebo cream. Maturitas 19: 3 (OCT 1994): 211-223.
5) GE Pierard, C Letawe, A Dowlati, C Pierardfranchimont. Effect of hormone replacement
therapy for menopause on the mechanical properties of skin. Journal of the American
Geriatrics Society 43:6: (JUN 1995): 662-665. HRT has a beneficial effect on stretching of
skin and thus may slow the progress of intrinsic cutaneous aging.
Reported 10/15/96